Cory Berkland

2.6k total citations · 1 hit paper
33 papers, 2.1k citations indexed

About

Cory Berkland is a scholar working on Pharmaceutical Science, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Cory Berkland has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 9 papers in Biomedical Engineering and 8 papers in Biomaterials. Recurrent topics in Cory Berkland's work include Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Drug Solubulity and Delivery Systems (5 papers). Cory Berkland is often cited by papers focused on Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Drug Solubulity and Delivery Systems (5 papers). Cory Berkland collaborates with scholars based in United States, Egypt and Thailand. Cory Berkland's co-authors include Daniel W. Pack, Amir Fakhari, Kyekyoon Kim, Kyekyoon Kim, Martin J. King, Kyekyoon Kevin Kim, Milind Singh, Michael S. Detamore, Emily J. Pollauf and Nashwa El‐Gendy and has published in prestigious journals such as Advanced Materials, Journal of Controlled Release and Acta Biomaterialia.

In The Last Decade

Cory Berkland

31 papers receiving 2.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment

2013 403 citations Amir Fakhari, Cory Berkland Acta Biomaterialia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cory Berkland United States	18	695	665	622	283	233	33	2.1k
Tze‐Wen Chung Taiwan	29	1.4k 2.0×	1.0k 1.5×	338 0.5×	516 1.8×	291 1.2×	95	2.9k
Hao Chang China	28	565 0.8×	944 1.4×	1.2k 1.9×	530 1.9×	103 0.4×	83	3.1k
Axel T. Neffe Germany	29	1.1k 1.6×	1.2k 1.7×	202 0.3×	527 1.9×	328 1.4×	120	3.2k
Marie‐Claire Venier‐Julienne France	30	1.1k 1.6×	676 1.0×	920 1.5×	752 2.7×	202 0.9×	49	2.8k
Rajeev Jain United States	7	1.0k 1.5×	566 0.9×	917 1.5×	379 1.3×	163 0.7×	7	2.1k
Yao Fu China	22	626 0.9×	407 0.6×	388 0.6×	379 1.3×	172 0.7×	105	2.5k
Marta Roldo United Kingdom	22	532 0.8×	613 0.9×	376 0.6×	184 0.7×	201 0.9×	49	1.6k
Won Ho Kong South Korea	20	617 0.9×	657 1.0×	174 0.3×	405 1.4×	190 0.8×	29	1.9k
Kaihui Nan China	30	980 1.4×	1.1k 1.6×	397 0.6×	624 2.2×	276 1.2×	96	2.8k
Nathalie Bock Australia	23	1.1k 1.6×	1.4k 2.1×	163 0.3×	259 0.9×	256 1.1×	58	2.5k

Countries citing papers authored by Cory Berkland

Since Specialization

Citations

This map shows the geographic impact of Cory Berkland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory Berkland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory Berkland more than expected).

Fields of papers citing papers by Cory Berkland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cory Berkland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory Berkland. The network helps show where Cory Berkland may publish in the future.

Co-authorship network of co-authors of Cory Berkland

This figure shows the co-authorship network connecting the top 25 collaborators of Cory Berkland. A scholar is included among the top collaborators of Cory Berkland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cory Berkland. Cory Berkland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Huan, Chad E. Groer, Xiaoqing Wu, et al.. (2025). Intralesional injection of CpG ODNs complexed with glatiramer acetate mitigates systemic cytokine toxicities and synergistically advances checkpoint blockade efficacy. Drug Delivery and Translational Research.

King, John V. Lin, et al.. (2025). Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetes. Drug Delivery and Translational Research. 16(1). 303–315.

Miller, Jonathan D., et al.. (2024). PDMS microspheres as rheological additives for PDMS-based DIW inks. Advanced Industrial and Engineering Polymer Research. 8(1). 1–9. 3 indexed citations

Fang, Wei Bin, Nicolas Bergeron, Qingting Hu, et al.. (2024). CCL2 signaling promotes skeletal muscle wasting in non-tumor and breast tumor models. Disease Models & Mechanisms. 17(8). 2 indexed citations

Miller, Jonathan D., et al.. (2021). Compression sensors constructed from ferromagnetic particles embedded within soft materials. MRS Communications. 11(2). 94–99. 3 indexed citations

Dormer, Nathan H., et al.. (2018). Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids. European Journal of Pharmaceutical Sciences. 126. 3–10. 11 indexed citations

Tima, Singkome, Songyot Anuchapreeda, Chadarat Ampasavate, Cory Berkland, & Siriporn Okonogi. (2017). Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. European Journal of Pharmaceutics and Biopharmaceutics. 114. 57–68. 29 indexed citations

El‐Gendy, Nashwa, et al.. (2015). NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(5). 341–352. 15 indexed citations

Kuehl, C.J., Nashwa El‐Gendy, & Cory Berkland. (2014). NanoClusters Surface Area Allows Nanoparticle Dissolution with Microparticle Properties. Journal of Pharmaceutical Sciences. 103(6). 1787–1798. 12 indexed citations

10.

El‐Gendy, Nashwa, et al.. (2013). NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation. International Journal of Pharmaceutics. 462(1-2). 19–28. 14 indexed citations

11.

Fakhari, Amir & Cory Berkland. (2013). Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomaterialia. 9(7). 7081–7092. 403 indexed citations breakdown →

12.

Thati, Sharadvi, et al.. (2013). Single-step grafting of aminooxy-peptides to hyaluronan: A simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis. Journal of Controlled Release. 168(3). 334–340. 29 indexed citations

13.

El‐Gendy, Nashwa, et al.. (2011). Nanocluster Budesonide Formulations Enhance Drug Delivery through Endotracheal Tubes. Journal of Pharmaceutical Sciences. 101(3). 1063–1072. 14 indexed citations

14.

Williams, S. Janette, Qun Wang, Ronal R. MacGregor, et al.. (2009). Adhesion of pancreatic beta cells to biopolymer films. Biopolymers. 91(8). 676–685. 48 indexed citations

15.

Singh, Milind, Cory Berkland, & Michael S. Detamore. (2008). Strategies and Applications for Incorporating Physical and Chemical Signal Gradients in Tissue Engineering. Tissue Engineering Part B Reviews. 14(4). 341–366. 152 indexed citations

16.

Pollauf, Emily J., Cory Berkland, Kyekyoon Kim, & Daniel W. Pack. (2005). In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres. International Journal of Pharmaceutics. 301(1-2). 294–303. 20 indexed citations

17.

Berkland, Cory, et al.. (2004). Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution. Journal of Controlled Release. 103(1). 149–158. 142 indexed citations

18.

Berkland, Cory, Kyekyoon Kevin Kim, & Daniel W. Pack. (2003). PLG Microsphere Size Controls Drug Release Rate Through Several Competing Factors. Pharmaceutical Research. 20(7). 1055–1062. 168 indexed citations

19.

Berkland, Cory, et al.. (2002). Precise control of PLG microsphere size provides enhanced control of drug release rate. Journal of Controlled Release. 82(1). 137–147. 315 indexed citations

20.

Berkland, Cory, Kyekyoon Kim, & Daniel W. Pack. (2001). Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. Journal of Controlled Release. 73(1). 59–74. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact